Infectious disease expert: Antibiotic resistance could create another headache post-coronavirus
With the coronavirus pandemic taking a toll on the health and well-being of the public and the federal government rushing to respond, the Washington Examiner spoke with one of the foremost experts on infectious diseases, Dr. Greg Frank.
Frank is the director of infectious disease policy at the Biotechnology Innovation Organization, where he leads several infectious diseases policy issues, including antimicrobial resistance and vaccine policy. BIO is a trade organization and lobbying group that represents the interests of the biotechnology industry. Biotechnology is technology based on biology used most often to create medicines and cure diseases, to create fuels and help produce food products.
Dr. Frank received his doctorate in immunology at the University of Pittsburgh and pursued his postdoctoral training at the Laboratory of Viral Diseases at the National Institute of Allergy and Infectious Diseases. He has published multiple scientific articles in the field of infectious disease. The interview has been lightly edited for clarity.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.